What is one reason why a physician might choose to prescribe a TCA over newer antidepressants?

Choosing to prescribe a tricyclic antidepressant (TCA) over newer antidepressants can indeed stem from cost considerations. TCAs have been around for a long time, which often makes them more affordable compared to newer classes of antidepressants like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). This is particularly significant in settings where patients may have limited insurance coverage or higher out-of-pocket costs for medications.

Furthermore, while newer medications can offer advantages such as improved tolerability and a lower incidence of certain side effects, not all patients can access these due to financial constraints. Thus, the affordability of TCAs plays a crucial role in their continued prescription by some physicians, especially in populations that prioritize cost in their treatment options. The history and established efficacy of TCAs in various patient populations further justify their use, particularly when considering healthcare economics.